BAY-1436032
- Generic Name
- BAY-1436032
BAY1436032 in Patients With Mutant IDH1(mIDH1) Advanced Acute Myeloid Leukemia (AML)
- First Posted Date
- 2017-04-25
- Last Posted Date
- 2019-05-14
- Lead Sponsor
- Bayer
- Target Recruit Count
- 27
- Registration Number
- NCT03127735
- Locations
- 🇩🇪
Universitätsklinikum Heidelberg, Heidelberg, Baden-Württemberg, Germany
🇩🇪Medizinische Hochschule Hannover (MHH), Hannover, Niedersachsen, Germany
🇩🇪Universitätsklinikum Leipzig AöR, Leipzig, Sachsen, Germany
Phase I Study of BAY1436032 in IDH1-mutant Advanced Solid Tumors
- First Posted Date
- 2016-04-21
- Last Posted Date
- 2024-12-18
- Lead Sponsor
- Bayer
- Target Recruit Count
- 81
- Registration Number
- NCT02746081
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath